- Home
- ALEC vs FDBC Comparison
ALEC vs FDBC Comparison
Compare ALEC & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALEC | FDBC |
|---|---|---|
| Founded | 2013 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.8M | 309.4M |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ALEC | FDBC |
|---|---|---|
| Price | $2.01 | $55.26 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $4.83 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 3.9K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.87% |
| EPS Growth | N/A | ★ 35.00 |
| EPS | N/A | ★ 2.63 |
| Revenue | ★ $21,045,000.00 | N/A |
| Revenue This Year | $2.03 | N/A |
| Revenue Next Year | $29.87 | N/A |
| P/E Ratio | ★ N/A | $20.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $39.87 |
| 52 Week High | $3.40 | $56.14 |
Technical Indicators
Market Signals| Indicator | ALEC | FDBC |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 61.26 |
| Support Level | $2.19 | $52.79 |
| Resistance Level | $2.60 | $56.14 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | -0.05 | 0.09 |
| Stochastic Oscillator | 27.63 | 97.31 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), the company provides a full range of banking, trust and financial services to individuals, small businesses and corporate customers. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. The company's segments include: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate, with the majority of revenue generating from the Commercial Real Estate segment.